Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTS
7151
CALL
DELISTED
Triple-S Management Corporation
GTS
| $449K | ﹤0.01% |
24,300
+1,600
| +7% | +$27.3K |
|
|
SCID
7152
DELISTED
Global X Scientific Beta Europe ETF
SCID
| $449K | ﹤0.01% |
17,253
+6,251
| +57% | +$156K |
|
|
IBMM
7153
DELISTED
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
| $449K | ﹤0.01% |
16,974
+6,629
| +64% | +$175K |
|
7154
PUT
Douglas Emmett
DEI
$1.97B
| $448K | ﹤0.01% |
10,200
-600
| -6% | -$25.9K |
|
7155
PUT
Icon
ICLR
$13.1B
| $448K | ﹤0.01% |
2,600
-15,100
| -85% | -$2.33M |
|
|
LJPC
7156
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $448K | ﹤0.01% |
114,075
+90,190
| +378% | +$533K |
|
7157
CALL
Century Aluminum
CENX
$4.61B
| $447K | ﹤0.01% |
59,500
-8,600
| -13% | -$59.6K |
|
7158
Ezcorp Inc
EZPW
$2.03B
| $447K | ﹤0.01% |
65,526
+2,376
| +4% | +$13.6K |
|
7159
CALL
Invesco Pharmaceuticals ETF
PJP
$522M
| $447K | ﹤0.01% |
+6,900
| New | +$420K |
|
7160
PUT
Revvity
RVTY
$14.4B
| $447K | ﹤0.01% |
4,600
-3,500
| -43% | -$312K |
|
7161
Erie Indemnity
ERIE
$13.6B
| $446K | ﹤0.01% |
+2,688
| New | +$475K |
|
7162
Mine Safety
MSA
$7.34B
| $446K | ﹤0.01% |
3,527
-12,575
| -78% | -$1.51M |
|
7163
Pilgrim's Pride
PPC
$7.55B
| $446K | ﹤0.01% |
13,640
-44,526
| -77% | -$1.39M |
|
7164
PUT
Travere Therapeutics
TVTX
$6.19B
| $446K | ﹤0.01% |
31,400
-32,000
| -50% | -$409K |
|
7165
PUT
Ameren
AEE
$29.4B
| $445K | ﹤0.01% |
5,800
-7,000
| -55% | -$532K |
|
7166
PUT
The Ensign Group
ENSG
$10.1B
| $445K | ﹤0.01% |
+9,800
| New | +$413K |
|
7167
CALL
Outfront Media
OUT
$5.21B
| $445K | ﹤0.01% |
16,865
-146,402
| -90% | -$3.77M |
|
7168
PUT
ProShares Ultra Health Care
RXL
$92.6M
| $445K | ﹤0.01% |
+14,000
| New | +$391K |
|
7169
iShares 0-5 Year TIPS Bond ETF
STIP
$16B
| $445K | ﹤0.01% |
+4,414
| New | +$443K |
|
7170
PUT
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
| $445K | ﹤0.01% |
+3,100
| New | +$455K |
|
|
SYNH
7171
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $445K | ﹤0.01% |
7,476
-22,439
| -75% | -$1.21M |
|
7172
Duluth Holdings
DLTH
$140M
| $444K | ﹤0.01% |
42,132
-17,751
| -30% | -$165K |
|
7173
CALL
Fidelity National Financial
FNF
$12.8B
| $444K | ﹤0.01% |
10,192
-56,576
| -85% | -$2.51M |
|
7174
CALL
H.B. Fuller
FUL
$3.03B
| $444K | ﹤0.01% |
8,600
-4,600
| -35% | -$228K |
|
7175
PUT
Kaiser Aluminum
KALU
$2.56B
| $444K | ﹤0.01% |
+4,000
| New | +$428K |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.